Euclidean Capital related stories
All articles and analysis
Kallyope scores $66 mln Series BNew York City-based Kallyope Inc, a biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, has raised $66 million in Series B financing. The investors included Lux Capital, The Column Group, Polaris Partners, Illumina Ventures, Alexandria Venture Investments, Euclidean Capital and Two Sigma Ventures.
- Ripple Foods racks up $65 mln Series C
Ripple Foods, a maker of nutritious plant-based dairy alternatives, has secured $65 million in Series C funding. Euclidean Capital led the round with participation from other investors that included Goldman Sachs, Fall Line Capital, GV, Prelude Ventures, S2G Ventures and Khosla Ventures.
CircleUp raises $125m for growth fundThe San Francisco-based firm will focus on early-stage consumer and retail brands.
- PMV Pharma bags $74 mln Series B
Cranbury, New Jersey-based PMV Pharmaceuticals Inc, a developer of small molecule drugs that treat cancer, has closed $74 million in Series B financing. Topspin Biotech Fund led the round with participation from Euclidean Capital, InterWest Partners, OrbiMed Advisors and Osage University Partners.